EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neurotransmitter‐Defined Degeneration Patterns in Sporadic and C9orf72 ‐Associated Amyotrophic Lateral Sclerosis: Predilection to GABAergic , Serotonergic, Opioid, Glutamatergic, Endocannabinoid, and Microglial Systems—Implications for Therapy Development

Marlene Tahedl, We Fong Siah, Jasmin Lope, Jennifer C Hengeveld, Mark A Doherty, Russell L McLaughlin, Orla Hardiman, Ee Ling Tan, Alison Toomey, Jana Kleinerova iD, Peter Bede

Annals of Neurology · 2026

DOI: 10.1002/ana.78316 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Neurology, 2026. Verfasst von Marlene Tahedl und 10 weiteren Autor:innen. Beteiligte Einrichtung: Computational Neuroimaging Group (CNG), School of Medicine, Trinity College Dublin, Dublin, Ireland. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Microglia, C9orf72 Protein, Neurotransmitter Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Amyotrophic lateral sclerosis (ALS) has a markedly distinctive clinical and neuroradiological signature, with the preferential involvement of specific brain networks and the apparent sparing of others. The molecular underpinnings of the strikingly selective anatomical vulnerability have not been fully elucidated to date despite the potential therapeutic relevance of characterizing neurotransmitter receptor‐defined susceptibility to degeneration.

Methods

A large neuroimaging study was undertaken with 258 participants to systematically evaluate topological associations between neurodegeneration and neurotransmitter expression distributions. Patients were stratified based on their genetic profile into sporadic and C90rf72 hexanucleotide repeat expansion carriers. Anatomical associations were evaluated between patterns of atrophy and topological neurotransmitter receptor distributions. Cross‐sectional and longitudinal trends were comprehensively evaluated over 4 consecutive timepoints.

Results

Our analyses reveal topological associations between neurodegeneration in sporadic ALS and GABA‐A receptor α5‐selective component (GABAa5), serotonin 1a receptor, and kappa opioid receptor expression maps. In addition to these networks, neuronal loss in patients with GGGGCC hexanucleotide repeat expansions exhibit predilection to glutamatergic, endocannabinoid, and microglial systems. Our multi‐timepoint longitudinal analyses reveal dynamic temporal associations between focal volume loss and neurotransmitter expression with increasing spatial associations with noradrenaline transporter and GABAa5, but high attrition rates preclude definite longitudinal inferences.

Interpretation

Our data suggest the preferential vulnerability of GABAergic, serotonergic, kappa opioid mediated networks in sporadic ALS. In C9orf72 ‐assocaited ALS, glutamatergic, endocannabinoid circuits are also susceptible and microglia‐mediated neuroinflammation is also implicated. The comprehensive evaluation of neurotransmitter‐receptor associations not only offer academic insights regarding pathophysiological processes in ALS, but may inform targeted therapy development strategies. ANN NEUROL 2026;100:948–961

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisMicrogliaC9orf72 ProteinNeurotransmitter AgentsHumansFemaleMaleMiddle AgedAgedCross-Sectional StudiesEndocannabinoidsLongitudinal StudiesBrain

Substanzen

C9orf72 ProteinNeurotransmitter AgentsC9orf72 protein, humanEndocannabinoids

Autor:innen und Institutionen

  • Computational Neuroimaging Group (CNG), School of Medicine, Trinity College Dublin, Dublin, Ireland.
  • Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland.
  • Department of Neurology, St James's Hospital, Dublin, Ireland.
  • The Irish FTD/FTLD Network, Dublin, Ireland.

ORCID-Profile: Jana Kleinerova

Zitieren

APA

Tahedl, M., Siah, W. F., Lope, J., Hengeveld, J. C., Doherty, M. A., McLaughlin, R. L., Hardiman, O., Tan, E. L., Toomey, A., Kleinerova, J., & Bede, P. (2026). Neurotransmitter‐Defined Degeneration Patterns in Sporadic and C9orf72 ‐Associated Amyotrophic Lateral Sclerosis: Predilection to GABAergic , Serotonergic, Opioid, Glutamatergic, Endocannabinoid, and Microglial Systems—Implications for Therapy Development. Annals of Neurology. https://doi.org/10.1002/ana.78316

Vancouver

Tahedl M, Siah WF, Lope J, Hengeveld JC, Doherty MA, McLaughlin RL, et al. Neurotransmitter‐Defined Degeneration Patterns in Sporadic and C9orf72 ‐Associated Amyotrophic Lateral Sclerosis: Predilection to GABAergic , Serotonergic, Opioid, Glutamatergic, Endocannabinoid, and Microglial Systems—Implications for Therapy Development. Annals of Neurology. 2026. doi:10.1002/ana.78316

BibTeX
@article{Tahedl2026,
  author = {Tahedl, Marlene and Siah, We Fong and Lope, Jasmin and Hengeveld, Jennifer C and Doherty, Mark A and McLaughlin, Russell L and Hardiman, Orla and Tan, Ee Ling and Toomey, Alison and Kleinerova, Jana and Bede, Peter},
  title = {Neurotransmitter‐Defined Degeneration Patterns in Sporadic and C9orf72 ‐Associated Amyotrophic Lateral Sclerosis: Predilection to GABAergic , Serotonergic, Opioid, Glutamatergic, Endocannabinoid, and Microglial Systems—Implications for Therapy Development},
  journal = {Annals of Neurology},
  year = {2026},
  doi = {10.1002/ana.78316}
}
Kostenlos starten →